CELU Celularity Inc. - Class A

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.

$2.31  +0.02 (0.66%)
As of 09/30/2022 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  08/08/2019
Outstanding shares:  142,384,167
Average volume:  1,297,437
Market cap:   $326,059,742
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP4Z4C5
Valuation   (See tab for details)
PE ratio:   -19.38
PB ratio:   3.54
PS ratio:   11.96
Return on equity:   -181.29%
Net income %:   -597.67%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy